Robust drug bioavailability and safety for rheumatoid arthritis therapy using D-amino acids-based supramolecular hydrogels
Long-term use of disease-modifying anti-rheumatic drugs (DMARDs) such as methotrexate (MTX) shows clinical benefits for rheumatoid arthritis (RA) treatment. However, there are growing concerns over the adverse effects of systemic drug administration. Therefore, a strategy that can enhance drug bioav...
Збережено в:
| Автори: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2022-06-01
|
| Серія: | Materials Today Bio |
| Предмети: | |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2590006422000941 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|